WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026944) METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026944    International Application No.:    PCT/CA2001/001354
Publication Date: 04.04.2002 International Filing Date: 26.09.2001
Chapter 2 Demand Filed:    22.04.2002    
IPC:
C12N 9/02 (2006.01), C12Q 1/26 (2006.01)
Applicants: XENON GENETICS, INC. [CA/CA]; #501-520 West 6th Street, Vancouver, British Columbia V5Z 4H5 (CA) (For All Designated States Except US).
BROWNLIE, Alison [CA/CA]; (CA) (For US Only)
Inventors: BROWNLIE, Alison; (CA)
Agent: MBM & CO.; P.O Box 809, Station B, Ottawa, Ontario K1P 5P9 (CA)
Priority Data:
60/235,640 26.09.2000 US
Title (EN) METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
(FR) TECHNIQUES ET COMPOSITIONS UTILISANT UNE NOUVELLE STEARYLE-COA DESATURASE HSCD5
Abstract: front page image
(EN)A cDNA encoding a novel human stearoy-CoA desaturase (dubbed 'hSCD5') as well as vectors and cells comprising such polynucleotide are disclosed. Also described are assay methods for determining the ability of small molecules and other chemical agents to increase or decrease he enzymatic activity and/or gene expression level of hSCD5 as well as processes for using such agents to treat, prevent or diagnose a variety of diseases and other conditions.
(FR)La présente invention concerne un ADNc codant pour une nouvelle stéaryle CoA désaturase humaine (plus brièvement dénommée «hSCD5») ainsi que des vecteurs et des cellules comprenant ces polynucléotides. Cette invention concerne aussi des techniques de dosage permettant de déterminer la capacité de petites molécules et d'autres agents chimiques d'augmenter l'activité enzymatique et/ou le niveau d'expression génique de hSCD5, ainsi que des processus d'utilisation de ces agents de façon à traiter, prévenir ou diagnostiquer diverses maladies et d'autres pathologies.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)